← SynDRA
DOLASTATIN-10
SynDRA canonical compound SYN0001992 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | TUBB |
|---|
| Mechanism of action | tubulin polymerization inhibitor |
|---|
All known targets
- TUBB
- TUBA1A
- TUBA1B
- TUBA1C
- TUBA3C
- TUBA3E
- TUBA4A
- TUBB1
- TUBB2A
- TUBB2B
- TUBB3
- TUBB4A
Mechanisms of action (all sources)
- TUBB4B INHIBITOR
- TUBB1 INHIBITOR
- TUBA3C INHIBITOR
- TUBA4A INHIBITOR
- TUBB3 INHIBITOR
- TUBA1A INHIBITOR
- TUBB4A INHIBITOR
- TUBB8 INHIBITOR
- TUBB INHIBITOR
- TUBA1B INHIBITOR
- TUBA1C INHIBITOR
- TUBA3E INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- Dolostatin 10
- Dolastatin 10
- NSC-376128
- EI946JT51X
- CHEBI:67357
- NSC376128
- Deo-Dola 10
- B720389K560
- RefChem:135576
- DTXCID801509960
- Dolastatin10
- CCRIS 7310
- DLS 10
- C42H68N6O6S
- UNII-EI946JT51X
- Dolastin
- MFCD00870128
- orb1296722
- SCHEMBL6423272
- WLZ3759
- GLXC-21112
- EX-A3357
- BDBM50216333
- TP1180
- AKOS040763913
- CS-1825
- NCGC00378623-03
- AS-81566
- BP-29360
- HY-15580
- DB-084593
- Dolastatin 10; DLS 10; NSC 376128
- NS00011842
- F77619
- F862797
- BRD-K78567475-001-01-4
- SR6
- dolastatin 10
Look up DOLASTATIN-10 in the interactive SynDRA portal →